These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 17287218)

  • 21. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.
    Latella G; Vetuschi A; Sferra R; Catitti V; D'Angelo A; Zanninelli G; Flanders KC; Gaudio E
    Liver Int; 2009 Aug; 29(7):997-1009. PubMed ID: 19422482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial cell-specific collagen type IV-α
    Funk SD; Bayer RH; Miner JH
    Am J Physiol Renal Physiol; 2019 May; 316(5):F830-F837. PubMed ID: 30724107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosis.
    Gross O; Schulze-Lohoff E; Koepke ML; Beirowski B; Addicks K; Bloch W; Smyth N; Weber M
    Nephrol Dial Transplant; 2004 Jul; 19(7):1716-23. PubMed ID: 15128880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
    Xu W; Wang LW; Shi JZ; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits.
    Shiomi M; Ito T
    Br J Pharmacol; 1999 Feb; 126(4):961-8. PubMed ID: 10193776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythropoietin decreases renal fibrosis in mice with ureteral obstruction: role of inhibiting TGF-beta-induced epithelial-to-mesenchymal transition.
    Park SH; Choi MJ; Song IK; Choi SY; Nam JO; Kim CD; Lee BH; Park RW; Park KM; Kim YJ; Kim IS; Kwon TH; Kim YL
    J Am Soc Nephrol; 2007 May; 18(5):1497-507. PubMed ID: 17389738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycophenolic acid displays IMPDH-dependent and IMPDH-independent effects on renal fibroblast proliferation and function.
    Petrova DT; Brandhorst G; Brehmer F; Gross O; Oellerich M; Armstrong VW
    Ther Drug Monit; 2010 Aug; 32(4):405-12. PubMed ID: 20592645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of connective tissue growth factor in experimental radiation nephropathy in rats.
    Liu DG; Wang TM
    Chin Med J (Engl); 2008 Oct; 121(19):1925-31. PubMed ID: 19080126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse.
    Hahm K; Lukashev ME; Luo Y; Yang WJ; Dolinski BM; Weinreb PH; Simon KJ; Chun Wang L; Leone DR; Lobb RR; McCrann DJ; Allaire NE; Horan GS; Fogo A; Kalluri R; Shield CF; Sheppard D; Gardner HA; Violette SM
    Am J Pathol; 2007 Jan; 170(1):110-25. PubMed ID: 17200187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laminin-1 reexpression in Alport mouse glomerular basement membranes.
    Abrahamson DR; Prettyman AC; Robert B; St John PL
    Kidney Int; 2003 Mar; 63(3):826-34. PubMed ID: 12631063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects.
    Park JK; Müller DN; Mervaala EM; Dechend R; Fiebeler A; Schmidt F; Bieringer M; Schäfer O; Lindschau C; Schneider W; Ganten D; Luft FC; Haller H
    Kidney Int; 2000 Oct; 58(4):1420-30. PubMed ID: 11012877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifibrotic, nephroprotective effects of paricalcitol versus calcitriol on top of ACE-inhibitor therapy in the COL4A3 knockout mouse model for progressive renal fibrosis.
    Rubel D; Stock J; Ciner A; Hiller H; Girgert R; Müller GA; Gross O
    Nephrol Dial Transplant; 2014 May; 29(5):1012-9. PubMed ID: 24198271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STAT3 inhibition attenuates the progressive phenotypes of Alport syndrome mouse model.
    Yokota T; Omachi K; Suico MA; Kamura M; Kojima H; Fukuda R; Motomura K; Teramoto K; Kaseda S; Kuwazuru J; Takeo T; Nakagata N; Shuto T; Kai H
    Nephrol Dial Transplant; 2018 Feb; 33(2):214-223. PubMed ID: 28992339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome.
    Andrews KL; Mudd JL; Li C; Miner JH
    Am J Pathol; 2002 Feb; 160(2):721-30. PubMed ID: 11839593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of alpha3/alpha4(IV) collagen from the glomerular basement membrane induces a strain-dependent isoform switch to alpha5alpha6(IV) collagen associated with longer renal survival in Col4a3-/- Alport mice.
    Kang JS; Wang XP; Miner JH; Morello R; Sado Y; Abrahamson DR; Borza DB
    J Am Soc Nephrol; 2006 Jul; 17(7):1962-9. PubMed ID: 16769745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis.
    Jones LK; O'Sullivan KM; Semple T; Kuligowski MP; Fukami K; Ma FY; Nikolic-Paterson DJ; Holdsworth SR; Kitching AR
    Nephrol Dial Transplant; 2009 Oct; 24(10):3024-32. PubMed ID: 19465557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
    Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
    Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The renal lesions of Alport syndrome.
    Heidet L; Gubler MC
    J Am Soc Nephrol; 2009 Jun; 20(6):1210-5. PubMed ID: 19470679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid-induced colorectal fibrosis.
    Latella G; Vetuschi A; Sferra R; Zanninelli G; D'Angelo A; Catitti V; Caprilli R; Flanders KC; Gaudio E
    Eur J Clin Invest; 2009 Feb; 39(2):145-56. PubMed ID: 19200168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role for transforming growth factor-beta1 in alport renal disease progression.
    Sayers R; Kalluri R; Rodgers KD; Shield CF; Meehan DT; Cosgrove D
    Kidney Int; 1999 Nov; 56(5):1662-73. PubMed ID: 10571774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.